Search - tctmd.com

Displaying 541 - 560 of 2580

Sort: Relevancy | Date

Presentation Fellows 2016

Practical Aspects of TAVR I: Procedural Planning, Imaging, and How to Do These Cases Safely

Presenter: Mark Reisman, Tamim Nazif

April 17, 2016

Presentation Fellows 2016

The TAVR Revolution: The Future of Aortic Stenosis Therapy

Presenter: Mark Reisman, Susheel Kodali

April 17, 2016

News Industry News

Tips for Convincing Your Boss to Attend TCT 2016

April 13, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

Hints of What’s to Come in New Coronary Revascularization AUC

Caitlin E. Cox

April 12, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

Yael L. Maxwell

April 04, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Daily News

分析预测到 2025 年世界五分之一人口为肥胖者

Yael L. Maxwell

April 02, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Daily News

One-Fifth of the World Will be Obese by 2025, Analysis Predicts

Yael L. Maxwell

April 02, 2016

News Daily News

One-Fifth of the World Will be Obese by 2025, Analysis Predicts

Yael L. Maxwell

April 02, 2016

News Daily News

微创二尖瓣手术结局良好且不会增加成本

Todd Neale

April 01, 2016

News Daily News

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

Todd Neale

April 01, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Daily News

Cirugía de válvula mitral mínimamente invasiva da buenos resultados sin aumentar los costos

Todd Neale

April 01, 2016

Advertisement

Practical Aspects of TAVR I: Procedural Planning, Imaging, and How to Do These Cases Safely

The TAVR Revolution: The Future of Aortic Stenosis Therapy

Tips for Convincing Your Boss to Attend TCT 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Hints of What’s to Come in New Coronary Revascularization AUC

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

分析预测到 2025 年世界五分之一人口为肥胖者

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

One-Fifth of the World Will be Obese by 2025, Analysis Predicts

One-Fifth of the World Will be Obese by 2025, Analysis Predicts

微创二尖瓣手术结局良好且不会增加成本

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Cirugía de válvula mitral mínimamente invasiva da buenos resultados sin aumentar los costos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content